Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001178913-12-003345
Filing Date
2012-11-30
Accepted
2012-11-30 06:03:06
Documents
1
Period of Report
2008-07-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT zk1212342.html 3/A  
1 OWNERSHIP DOCUMENT zk1212342.xml 3/A 2673
  Complete submission text file 0001178913-12-003345.txt   4214
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address HAADMUR MEBUYON 26 HARNOT JERUSALEM L3 95403
Business Address
JACOB HAROLD (Reporting) CIK: 0001443692 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-50298 | Film No.: 121233139